This page will host Events plug-in for all Clarion and trade events.

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

25.10 -0.92 (-3.54%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,014,460
Open	25.79
Bid (Size)	25.09 (2,400)
Ask (Size)	25.12 (100)
Prev. Close	26.02
Today's Range	25.07 - 25.94
52wk Range	19.35 - 66.85
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT

Today 17:11 EDT

From Pomerantz LLP

Via GlobeNewswire

EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH

March 23, 2026

Updated European Association of Urology guidelines reflect growing clinical evidence supporting Aquablation therapy in the surgical treatment of benign prostatic hyperplasia

From PROCEPT BioRobotics

Via GlobeNewswire

Performance

YTD	-18.4%	-18.4%
1 Month	-8.3%	-8.3%
3 Month	-26.7%	-26.7%
6 Month	-34.7%	-34.7%
1 Year	-58.8%	-58.8%

More News

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT

March 17, 2026

From Pomerantz LLP

Via GlobeNewswire

PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy

March 12, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics Corp (NASDAQ:PRCT) Plummets 27% After Q4 Earnings Miss and Slashed 2026 Guidance ↗

February 25, 2026

Via Chartmill

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT

March 10, 2026

From Pomerantz LLP

Via GlobeNewswire

Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

March 10, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

March 10, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

March 09, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm

March 08, 2026

From The Schall Law Firm

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics Corporation - PRCT

March 03, 2026

From Pomerantz LLP

Via GlobeNewswire

There are notable gap-ups and gap-downs in today's session. ↗

February 26, 2026

Via Chartmill

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

February 26, 2026

Via Chartmill

PROCEPT BioRobotics® Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth

February 26, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics Stock Hits 52-Week Low - Here's Why ↗

February 26, 2026

Via Benzinga

PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20 ↗

February 26, 2026

Via Stocktwits

Top movers in Wednesday's after hours session ↗

February 25, 2026

Via Chartmill

PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance

February 25, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day

February 23, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference

February 04, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

After a 60% Slide, One Fund Cuts Exposure to This Healthcare Tech Stock by $12.5 Million ↗

February 01, 2026

Via The Motley Fool

PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City

January 26, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

3 Underrated Robotics Stocks Poised for Huge Gains ↗

December 15, 2025

Via MarketBeat

PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025

November 20, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance

November 04, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

Frequently Asked Questions

Is PROCEPT BioRobotics Corporation - Common Stock publicly traded?

Yes, PROCEPT BioRobotics Corporation - Common Stock is publicly traded.

What exchange does PROCEPT BioRobotics Corporation - Common Stock trade on?

PROCEPT BioRobotics Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for PROCEPT BioRobotics Corporation - Common Stock?

The ticker symbol for PROCEPT BioRobotics Corporation - Common Stock is PRCT on the Nasdaq Stock Market

What is the current price of PROCEPT BioRobotics Corporation - Common Stock?

The current price of PROCEPT BioRobotics Corporation - Common Stock is 25.10

When was PROCEPT BioRobotics Corporation - Common Stock last traded?

The last trade of PROCEPT BioRobotics Corporation - Common Stock was at 03/24/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.